Skip to content
For Digital Health

Operate a defensible HIPAA posture for a health platform you ship.

Valentra Labs runs the cybersecurity program for a digital health company as one operating layer on Valentra Nexus — assets, risk, controls, and the evidence behind them on a single record — so a product team carries a defensible HIPAA posture into every diligence and customer review without slowing delivery.

PHI in software that ships

A digital health company handles PHI inside software it ships and updates constantly. Security has to keep pace with the release cycle, and every enterprise customer and investor diligence asks for evidence the team is too busy building to assemble — so HIPAA posture lives in a slide deck that is stale the day after it is written.

Valentra Labs operates the program alongside the product. Valentra Nexus carries the technical and administrative safeguards as live controls, keeps the evidence behind them current as the platform changes, and sequences security work against the release cycle — producing a board-ready Decision Packet a digital health team can hand to a customer's security review or an investor's diligence without a fire drill.

Operate the safeguards, not a slide

The HIPAA Security Rule path walks a product team through how the administrative, physical, and technical safeguards run as live controls against a moving codebase — current evidence, not an annual snapshot. It is the posture a diligence reviewer actually tests.

One Decision Packet for diligence

For every customer security review and investor diligence, the program produces a single board-ready Decision Packet — the situation, options, recommendation, evidence, and approval chain. It is the same artifact every Valentra Labs program produces, generated by Valentra Nexus.

Decision Packet · v1.0

Q2 2026 — Crown-Jewel Risk Disposition

pkt_2026-04-17_a3f8e1

Situation

Q2 program review covers the crown-jewel ePHI store and its supporting control envelope. 487 endpoints catalogued across three network segments; 12 unsanctioned SaaS surfaces detected by the shadow-IT scan. Continuous monitoring posture is operating; the residual question is risk acceptance for two compensating-control gaps surfaced this cycle.

Risk & Impact

14 critical findings scored against the revenue-at-risk model. Two compensating gaps (vendor-SOC-2 attestation lapse + patch-cycle #38 awaiting CAB sign-off) carry residual risk of $1.4M in unmitigated regulatory exposure if a HITRUST audit lands before remediation closes. Patient-data confidentiality remains the load-bearing impact dimension.

Options

  1. Accept residual risk through Q3, with quarterly board re-review.
  2. Accelerate remediation by re-prioritizing the patch cycle ahead of the planned Q3 platform migration (cost: 2 engineer-weeks).
  3. Transfer risk via expanded cyber-insurance rider (cost: $48K/yr premium delta; coverage gap on ePHI exfiltration remains).

Recommendation

Pursue Option 2 — accelerate remediation. The 2 engineer-weeks of effort cost is recoverable in Q3; the residual exposure is asymmetric (regulatory floor of $1.4M vs. ~$120K labor delta). Document the patch-cycle re-prioritization as a logged decision with the program owner; close the SOC-2 attestation gap via vendor outreach in the same window. Insurance rider deferred to Q4 review.

Evidence

Twelve evidence artifacts back the recommendation — asset inventory, control mapping, vendor SOC-2 status, residual-risk model, patch-cycle telemetry, and the prior packet's audit trail. One control attestation is overridden with a documented compensating-control narrative; two vendor attestations are pending the Q2 refresh window.
ArtifactHashStatusDetailCaptured
Asset inventory snapshot — 487 endpoints#a3f8e1b2verified—
Control mapping cross-walk — 93 controls#b7c4d9e0verified—
Vendor SOC-2 attestation — current#c9d0e2f1pendingRefresh window opens 2026-05-12; vendor confirmed window…
Vendor SOC-2 attestation — secondary processor#d2e3f4a5pending—
Residual-risk model — revenue-at-risk#e1f2a3b4verified—
Patch cycle #38 — CAB queue position#f3a4b5c6overridden—
Overridden per compensating-control narrative — see attached
Penetration test report — Q1 follow-up#a5b6c7d8stale—
Prior packet audit trail — pkt_2026-01-09_b8c4e2#b6c7d8e9verified—

Approval Chain

CIO and CISO have signed. The CCO signature is pending receipt of the vendor-SOC-2 refresh; the program owner has logged the override and the compensating-control narrative.
  1. Chief Information OfficerM. AlvarezSigned 2026-04-17T14:08:11Z
  2. Chief Information Security OfficerJ. ParkSigned 2026-04-17T14:18:42Z
  3. Chief Compliance Officer—Pending signatureAwaiting vendor SOC-2 refresh — window opens 2026-05-12
Generated by Valentra Nexuspkt_2026-04-17_a3f8e1

Aligned to the frameworks you report against

The program maps each operating stage — asset, risk, control, evidence, work, decision — to the frameworks a digital health buyer and auditor expect, so the posture holds as the platform evolves. Valentra Nexus carries the full framework-alignment grid; see how the stages line up on the platform page.

See the framework alignment on Valentra Nexus

Strategy Call See Valentra Nexus

Valentra Labs runs the cybersecurity program for a digital health company on Valentra Nexus — safeguards operated as live controls with current evidence — so a product team carries a defensible HIPAA posture into customer security reviews and investor diligence without a fire drill.

as of